Growth Metrics

Nexgel (NXGL) Change in Accured Expenses (2018 - 2025)

Nexgel (NXGL) has disclosed Change in Accured Expenses for 8 consecutive years, with -$4000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Accured Expenses rose 78.95% year-over-year to -$4000.0, compared with a TTM value of -$82000.0 through Sep 2025, down 90.7%, and an annual FY2024 reading of -$434000.0, down 2072.73% over the prior year.
  • Change in Accured Expenses was -$4000.0 for Q3 2025 at Nexgel, down from $200000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $200000.0 in Q2 2025 and bottomed at -$302000.0 in Q4 2024.
  • Average Change in Accured Expenses over 5 years is -$7157.9, with a median of -$2000.0 recorded in 2022.
  • The sharpest move saw Change in Accured Expenses skyrocketed 1450.0% in 2022, then plummeted 1494.44% in 2024.
  • Year by year, Change in Accured Expenses stood at $3000.0 in 2021, then crashed by 1266.67% to -$35000.0 in 2022, then soared by 354.29% to $89000.0 in 2023, then plummeted by 439.33% to -$302000.0 in 2024, then surged by 98.68% to -$4000.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for NXGL at -$4000.0 in Q3 2025, $200000.0 in Q2 2025, and $24000.0 in Q1 2025.